Legal Representation
Attorney
Abe Jentry Shanehsaz
USPTO Deadlines
Application History
11 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 16, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Jun 16, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Jun 11, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 11, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 11, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Apr 8, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Apr 8, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Apr 8, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Apr 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Apr 6, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 2, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting public awareness of Alzheimer's, dementia and brain diseases and patient registries, research, patient advocacy, political measures, public support, and fundraising related thereto; Promoting the interests of patients with Alzheimer's, dementia and brain disease by means of public advocacy; Promoting public awareness of health care issues for patients with Alzheimer's, dementia, and brain disease by means of public advocacy; Charitable services, namely, organizing and developing charitable giving programs of others that aim to improve the lives of Alzheimer's, dementia and brain disease patients, their caregivers and families; Business services, namely, administration of a program for enabling participants to receive expedited services for Alzheimer's care and research, provided for patients, their caregivers, families, and researchers; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in neuroscience clinical trials; Promoting the services of others related to maintaining a registry of participants in neuroscience clinical trials relating to the treatment and prevention of Alzheimer's and dementia
First Use Anywhere:
Jul 22, 2015
First Use in Commerce:
Jul 22, 2015
Additional Information
Pseudo Mark
AFRICAN AMERICANS AGAINST ALZHEIMERS
Classification
International Classes
035